Stock listing
OTC:MBCI MabCure, Inc. Stock
Follow MabCure, Inc. into a list and get an email when it puts out news.
Share price · OTC:MBCI
$0.0001 USD 0.0000 (0.0%)
Close on Nov 16, 2026
- Day range
- $0.0001 – $0.0001 USDNov 16, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.0001 – $0.0005 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $9 USDMedian day 0 shares · 29 days with no trades · last 3 months, Aug 17, 2026 – Nov 16, 2026

Daily closes
Last 3 months, Aug 17, 2026 – Nov 16, 2026 · OTC:MBCI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | -0.0003 | -75.0% | $0.0001 | $0.0001 | $0.0001 | 15,000 | |
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 | |
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 | |
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 | |
| $0.0004 | 0.0000 | 0.0% | $0.0004 | $0.0004 | $0.0004 | 0 | |
| $0.0004 | -0.0001 | -20.0% | $0.0004 | $0.0004 | $0.0004 | 125 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 5,000 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 200 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 1,400 | |
| $0.0005 | 0.0000 | 0.0% | $0.0001 | $0.0005 | $0.0001 | 3,300 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | +0.0003 | +150.0% | $0.0005 | $0.0005 | $0.0005 | 241 | |
| $0.0002 | +0.0001 | +100.0% | $0.0002 | $0.0002 | $0.0002 | 5,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 100 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 10,032 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | -0.0002 | -66.7% | $0.0005 | $0.0005 | $0.0001 | 250 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 1,243,248 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 |
- Ticker
- OTC:MBCI
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Valuation
price Nov 16, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 1.56
Financials
Annual, in USD
Income statement
| Line | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|
| Revenue | 500.0K | 0 | 0 | 0 | ||
| Cost of revenue | 0 | 0 | 0 | 0 | ||
| Gross profit | 500.0K | 0 | 0 | 0 | ||
| Research and development | 390.6K | 352.0K | 402.7K | 3.81K | ||
| Selling, general and administrative | 819.1K | 667.4K | 730.2K | 528.3K | ||
| Operating income | -709.7K | -1.02M | -1.36M | -536.0K | -106.3K | -4.00K |
| Depreciation and amortization | 32.7K | 43.1K | 39.8K | 4.05K | ||
| EBITDA | -677.1K | -976.3K | -1.32M | -531.9K | ||
| Interest expense | 186.7K | 206.9K | 16.7K | 970 | ||
| Income before tax | -12.3M | -1.23M | -1.37M | -530.5K | ||
| Income tax | 186.7K | 206.9K | 16.7K | 970 | 106.3K | 4.00K |
| Net income | -12.5M | -1.43M | -1.39M | -531.5K | -106.3K | -4.00K |
| Earnings per share, basic | -0.20 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 |
Balance sheet
| Line | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 146.4K | 3.42K | 214.5K | 811.4K | 45.0K | |
| Receivables | 44.9K | 31.9K | 10.6K | |||
| Current assets | 159.2K | 56.2K | 278.1K | 838.6K | 51.0K | |
| Property, plant and equipment | 41.9K | 123.9K | 169.7K | 166.2K | ||
| Total assets | 4.81M | 16.2M | 18.9M | 19.5M | 51.0K | |
| Accounts payable | 630.2K | 286.0K | 152.3K | 97.0K | 4.00K | |
| Current liabilities | 935.1K | 466.2K | 776.2K | 194.9K | 49.3K | |
| Long-term debt | 16.3K | 56.9K | ||||
| Total debt | 261.2K | 185.8K | 651.4K | 181.3K | ||
| Total liabilities | 935.1K | 482.5K | 833.0K | 286.5K | 49.3K | |
| Shareholders' equity | 3.88M | 15.7M | 18.1M | 19.2M | -49.3K | 51.0K |
| Shares outstanding | 63.7M | 62.1M | 60.4M | 43.1M | 49.7M | 7.74M |
Cash flow
| Line | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|
| Cash from operations | -61.4K | -691.8K | -1.03M | -455.1K | -90.3K | -6.00K |
| Capital spending | -1.26K | -14.0K | -44.4K | -170.2K | 0 | 0 |
| Free cash flow | -62.7K | -705.8K | -1.08M | -625.3K | -90.3K | -6.00K |
| Cash from investing | 53.2K | -14.0K | -44.4K | -170.2K | ||
| Cash from financing | 166.8K | 503.4K | 491.3K | 1.44M | 45.3K | 51.0K |
| Share buybacks | 15.8K | 500.0K | 500.0K | 1.30M | ||
| Change in cash | 143.0K | -211.1K | -597.0K | 811.4K | -45.0K | 45.0K |
Cap table
Built by 6ix from MabCure, Inc.’s releases
- Common shares
- 781,087
- Fully diluted
- 781,087
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 781,087 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 781,087 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gad Berdugo Other companies: Immune Pharmaceuticals Inc (CFO & SVP · Jun 3, 2014 – May 8, 2015 · Past) | Director · Sep 24, 2010 – May 19, 2011 · Past |
| Ron Kalfus Other companies: MDxHealth SA (Chief Financial Officer · Since at least Mar 18, 2026) | CFO, Secretary and Treasurer · Dec 1, 2008 – May 19, 2011 · Past |
| Charles Thomas Tackney | Chief Scientific Officer · May 19, 2011 – May 19, 2011 · Past |
| Elisha Orr | Executive VP CSO · Jul 7, 2008 – Jul 7, 2008 · Past |
Log in to ask 6ix AI your own questions about MabCure, Inc.